Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.

Boyapati, Ray K; Torres, Joana; Palmela, Carolina; Parker, Claire E; Silverberg, Orli M; Upadhyaya, Sonam D; Nguyen, Tran M; Colombel, Jean-Frédéric

Boyapati, Ray K; Torres, Joana; Palmela, Carolina; Parker, Claire E; Silverberg, Orli M; Upadhyaya, Sonam D; Nguyen, Tran M; Colombel, Jean-Frédéric.

Affiliation

Boyapati RK; Department of Gastroenterology, Monash Health, Clayton, Victoria, Australia.

Cochrane Database Syst Rev ; 5: CD012540, 2018 May 12.

Article in En | MEDLINE | ID: mdl-29756637

Subject(s)

Azathioprine/therapeutic use; Crohn Disease/therapy; Gastrointestinal Agents/therapeutic use; Immunosuppressive Agents/therapeutic use; Infliximab/therapeutic use; Withholding Treatment; Adult; Combined Modality Therapy/methods; Crohn Disease/complications; Crohn Disease/drug therapy; Feasibility Studies; Humans; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Secondary Prevention/methods

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azathioprine / Gastrointestinal Agents / Crohn Disease / Withholding Treatment / Infliximab / Immunosuppressive Agents Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: Cochrane Database Syst Rev Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2018 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google